logo
搜索
菜单

eliminatio的搜索结果

当前1/7页
排序: 今日浏览数
Quantification of Adeno-Associated Viral Genomes in Purified Vector Samples by Digital Droplet Polymerase Chain Reaction 10.3791/67252-v
Quantification of Adeno-Associated Viral Genomes in Purified Vector Samples by Digital Droplet Polymerase Chain Reaction
Whole Genome Sequencing for Rapid Characterization of Rabies Virus Using Nanopore Technology 10.3791/65414-v
Whole Genome Sequencing for Rapid Characterization of Rabies Virus Using Nanopore Technology
Microinjection Method for Anopheles gambiae Embryos 10.3791/62591-v 05:39 min
Microinjection Method for Anopheles gambiae Embryos
Small-Cage Laboratory Trials of Genetically-Engineered Anopheline Mosquitoes 10.3791/62588-v
Small-Cage Laboratory Trials of Genetically-Engineered Anopheline Mosquitoes
Improving Small RNA-seq: Less Bias and Better Detection of 2′-O-Methyl RNAs 10.3791/60056-v 08:49 min
Improving Small RNA-seq: Less Bias and Better Detection of 2′-O-Methyl RNAs
Selective Cell Elimination from Mixed 3D Culture Using a Near Infrared Photoimmunotherapy Technique 10.3791/53633-v 05:18 min
Selective Cell Elimination from Mixed 3D Culture Using a Near Infrared Photoimmunotherapy Technique
6.4: COVID-19 / Coronavirus Outbreak: A Rapidly Deployable Medical Facility Optimized for Epidemics (Smart Pod) 01:19 min
6.4: COVID-19 / Coronavirus Outbreak: A Rapidly Deployable Medical Facility Optimized for Epidemics (Smart Pod)
23.6: Nursing Assessment of the Genitourinary System I: Health History 01:21 min
23.6: Nursing Assessment of the Genitourinary System I: Health History
15.2: Pharmacokinetic–Pharmacodynamic Relationship: Dose to Pharmacological Effect 01:28 min
15.2: Pharmacokinetic–Pharmacodynamic Relationship: Dose to Pharmacological Effect
14.7: Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters 01:16 min
14.7: Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
13.22: Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant 01:25 min
13.22: Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
13.18: Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment 01:08 min
13.18: Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
13.16: Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug 01:14 min
13.16: Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
8.8: Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance 01:23 min
8.8: Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
7.6: One-Compartment Model: IV Infusion 01:09 min
7.6: One-Compartment Model: IV Infusion
6.14: Clearance Models: Compartment Models 01:25 min
6.14: Clearance Models: Compartment Models
6.4: Renal Drug Excretion: Glomerular Filtration 01:02 min
6.4: Renal Drug Excretion: Glomerular Filtration
5.6: Phase I Reactions: Hydrolytic Reactions 01:15 min
5.6: Phase I Reactions: Hydrolytic Reactions
3.20: Factors Influencing Drug Absorption: Presystemic Elimination 01:24 min
3.20: Factors Influencing Drug Absorption: Presystemic Elimination
1.3: Drug Concentration Versus Time Correlation 01:15 min
1.3: Drug Concentration Versus Time Correlation
返回顶部